Objective: Diagnosis of pregnancy-associated osteoporosis is often delayed and therapeutic interventions insufficient.
Study Design: A 28-year-old patient (BMI=18.6) with no additional risks for osteoporosis experienced acute lumbosacral pain two months postpartum, while lactating. After conservative therapy, thoracic and lumbar spine were X-rayed: severe pregnancy-associated osteoporosis with vertebral fractures was diagnosed. 2-year treatment with i. v. bisphosphonate ibandronate was initiated (2 mg every 3 months) and calcium and vitamin D supplementation.
Results: Rapid improvement was observed. Conclusion: In cases with multiple fractures i. v. bisphosphonate leads to substantial decrease of symptoms and further fractures and significant increase of bone mass density (BMD).
Conclusion: In severe cases of pregnancy-associated osteoporosis with multiple fractures i. v. biphosphonate therapy leads to a decrease of symptoms and fracture risk and an increase of bone mass density (BMD).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2007-967091 | DOI Listing |
This case report illustrates that in vitro fertilization (IVF) may be a potential risk factor for pregnancy-associated osteoporosis (PAO), highlighting the need for awareness and monitoring of bone health in women undergoing IVF treatments. PAO is a rare disease resulting from an imbalance of calcium in the body during pregnancy and lactation and presenting with fragility fractures. PAO occurs in late pregnancy or early postpartum period.
View Article and Find Full Text PDFJ Orthop Case Rep
January 2024
Department of Orthopedics, Government Medical College, Kannur, Kerala, India.
Osteoporos Int
December 2023
Faculty of Medicine, Philipps-University of Marburg, Marburg, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!